Boundless Bio Announces Jami Rubin as Chief Financial Officer
Boundless Bio announced the appointment of Jami Rubin as Chief Financial Officer. Jami brings more than 30 years of leadership experience in the biopharma industry as a top financial executive, equity analyst, investment banker, board member, and venture partner. Jami was most recently Chief Financial Officer of EQRx.
Boundless Bio is a biotechnology company focused on developing novel therapeutics for cancer treatment.